Bone Tissue Engineering: Past-Present-Future.

[1]  FranquesaMarcella,et al.  No Evidence for Circulating Mesenchymal Stem Cells in Patients with Organ Injury , 2014 .

[2]  T. Ma,et al.  Preconditioning Stem Cells for In Vivo Delivery , 2014, BioResearch open access.

[3]  BattiwallaMinoo,et al.  Bone marrow mesenchymal stromal cells to treat complications following allogeneic stem cell transplantation. , 2014 .

[4]  M. Kloppenburg,et al.  An emerging player in knee osteoarthritis: the infrapatellar fat pad , 2013, Arthritis Research & Therapy.

[5]  D. Schaffer,et al.  Biophysical regulation of epigenetic state and cell reprogramming. , 2013, Nature materials.

[6]  F. Farina,et al.  Umbilical cord revisited: from Wharton's jelly myofibroblasts to mesenchymal stem cells. , 2013, Histology and histopathology.

[7]  D. Gridley,et al.  Rapid and efficient reprogramming of human fetal and adult blood CD34+ cells into mesenchymal stem cells with a single factor , 2013, Cell Research.

[8]  Y. Hoki,et al.  Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells , 2013, Nature.

[9]  Julie V. Harness,et al.  Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. , 2012, Cell stem cell.

[10]  Rocky S Tuan,et al.  Concise Review: The Clinical Application of Mesenchymal Stem Cells for Musculoskeletal Regeneration: Current Status and Perspectives , 2012, Stem cells translational medicine.

[11]  N. Tajiri,et al.  Amniotic Fluid as a Rich Source of Mesenchymal Stromal Cells for Transplantation Therapy , 2011, Cell transplantation.

[12]  P. Leoni,et al.  Human Mesenchymal Stem Cells from Chorionic Villi and Amniotic Fluid are not Susceptible to Transformation after Extensive in Vitro Expansion , 2011, Cell transplantation.

[13]  Shinn-Zong Lin,et al.  Differentiation of Stem Cells: Strategies for Modifying Surface Biomaterials , 2011, Cell transplantation.

[14]  C. Kaeding,et al.  Accelerated chondrogenesis in nanofiber polymeric scaffolds embedded with BMP-2 genetically engineered chondrocytes , 2010 .

[15]  A. Vepsäläinen,et al.  Mitochondrial function determines the viability and osteogenic potency of human mesenchymal stem cells. , 2010, Tissue engineering. Part C, Methods.

[16]  D. Jones,et al.  Stem cells and the niche: a dynamic duo. , 2010, Cell stem cell.

[17]  S. Scaglione,et al.  Short-time survival and engraftment of bone marrow stromal cells in an ectopic model of bone regeneration. , 2010, Tissue engineering. Part A.

[18]  A. Mikos,et al.  Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements. , 2010, Tissue engineering. Part A.

[19]  S. Bellis,et al.  Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix-mimicking ligands in a biomimetic self-assembled peptide amphiphile nanomatrix. , 2009, Biomacromolecules.

[20]  B. Uygun,et al.  Effects of immobilized glycosaminoglycans on the proliferation and differentiation of mesenchymal stem cells. , 2009, Tissue engineering. Part A.

[21]  E. Place,et al.  Complexity in biomaterials for tissue engineering. , 2009, Nature materials.

[22]  Thomas J Webster,et al.  Biologically inspired rosette nanotubes and nanocrystalline hydroxyapatite hydrogel nanocomposites as improved bone substitutes , 2009, Nanotechnology.

[23]  Li Ren,et al.  Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. , 2009, Tissue engineering. Part B, Reviews.

[24]  R. Schüle,et al.  FHL2 mediates dexamethasone‐induced mesenchymal cell differentiation into osteoblasts by activating Wnt/β‐catenin signaling‐dependent Runx2 expression , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  Shara M. Dellatore,et al.  Mimicking stem cell niches to increase stem cell expansion. , 2008, Current opinion in biotechnology.

[26]  K. Anseth,et al.  Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. , 2008, Nature materials.

[27]  Duncan Sutherland,et al.  Nanomechanotransduction and Interphase Nuclear Organization influence on genomic control , 2007, Journal of cellular biochemistry.

[28]  R. Jilka,et al.  Extracellular Matrix Made by Bone Marrow Cells Facilitates Expansion of Marrow‐Derived Mesenchymal Progenitor Cells and Prevents Their Differentiation Into Osteoblasts , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  B. Nebe,et al.  Spark plasma sintering synthesis of porous nanocrystalline titanium alloys for biomedical applications. , 2007, Biomolecular engineering.

[30]  Kam W Leong,et al.  Synthetic nanostructures inducing differentiation of human mesenchymal stem cells into neuronal lineage. , 2007, Experimental cell research.

[31]  F Peyrin,et al.  Engineering of bone using bone marrow stromal cells and a silicon-stabilized tricalcium phosphate bioceramic: evidence for a coupling between bone formation and scaffold resorption. , 2007, Biomaterials.

[32]  D. Velten,et al.  Biomimetic implant coatings. , 2007, Biomolecular engineering.

[33]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[34]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[35]  A. Kundu,et al.  Vitronectin and collagen I differentially regulate osteogenesis in mesenchymal stem cells. , 2006, Biochemical and biophysical research communications.

[36]  A. Kundu,et al.  Adhesion of mesenchymal stem cells to polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation. , 2006, Journal of biomedical materials research. Part A.

[37]  R. Oreffo,et al.  Osteoprogenitor response to semi-ordered and random nanotopographies. , 2006, Biomaterials.

[38]  Thomas J Webster,et al.  Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. , 2006, Biomaterials.

[39]  G. Martino,et al.  The therapeutic potential of neural stem cells , 2006, Nature Reviews Neuroscience.

[40]  M. Walter,et al.  Regulation of FOXC1 Stability and Transcriptional Activity by an Epidermal Growth Factor-activated Mitogen-activated Protein Kinase Signaling Cascade* , 2006, Journal of Biological Chemistry.

[41]  M. Sheetz,et al.  Local force and geometry sensing regulate cell functions , 2006, Nature Reviews Molecular Cell Biology.

[42]  C. Wilkinson,et al.  Osteoprogenitor response to defined topographies with nanoscale depths. , 2006, Biomaterials.

[43]  P. Janmey,et al.  Tissue Cells Feel and Respond to the Stiffness of Their Substrate , 2005, Science.

[44]  D. Discher,et al.  Power-law rheology of isolated nuclei with deformation mapping of nuclear substructures. , 2005, Biophysical journal.

[45]  Benjamin G. Keselowsky,et al.  Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Ahmed El-Ghannam,et al.  Bone reconstruction: from bioceramics to tissue engineering , 2005, Expert review of medical devices.

[47]  Rudy Juliano,et al.  Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. , 2004, Molecules and cells.

[48]  G. Xiao,et al.  Regulation of the osteoblast‐specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways , 2003, Journal of cellular biochemistry.

[49]  S. Hollister,et al.  Optimal design and fabrication of scaffolds to mimic tissue properties and satisfy biological constraints. , 2002, Biomaterials.

[50]  R. Cancedda,et al.  Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice , 2002, Gene Therapy.

[51]  H. Lorenz,et al.  Rat extramedullary adipose tissue as a source of osteochondrogenic progenitor cells. , 2002, Plastic and reconstructive surgery.

[52]  T. Lim,et al.  Induction of Ectopic Bone Formation by Using Human Periosteal Cells in Combination with a Novel Scaffold Technology , 2002, Cell transplantation.

[53]  M. Hedrick,et al.  Myogenic Differentiation by Human Processed Lipoaspirate Cells , 2002, Plastic and reconstructive surgery.

[54]  P. Bianco,et al.  Stem cells in tissue engineering , 2001, Nature.

[55]  A. Simpson,et al.  Osteoprogenitor cells of mature human skeletal muscle tissue: an in vitro study. , 2001, Bone.

[56]  N. Mahmud,et al.  Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. , 2001, Human gene therapy.

[57]  L. Bonassar,et al.  Replacement of an avulsed phalanx with tissue-engineered bone. , 2001, The New England journal of medicine.

[58]  Mara Riminucci,et al.  Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications , 2001, Stem cells.

[59]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[60]  R Cancedda,et al.  Repair of large bone defects with the use of autologous bone marrow stromal cells. , 2001, The New England journal of medicine.

[61]  J. Lee,et al.  Osteoprogenitor cells within skeletal muscle , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[62]  P. Bianco,et al.  Marrow stromal stem cells. , 2000, The Journal of clinical investigation.

[63]  T. VandenDriessche,et al.  Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice. , 2000, Human gene therapy.

[64]  G. Karsenty,et al.  MAPK Pathways Activate and Phosphorylate the Osteoblast-specific Transcription Factor, Cbfa1* , 2000, The Journal of Biological Chemistry.

[65]  M. Sayer,et al.  Resorbable bioceramics based on stabilized calcium phosphates. Part I: rational design, sample preparation and material characterization. , 1999, Biomaterials.

[66]  C. Lange,et al.  Hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34-, Sca-1+, Thy-1(low), c-kit+ stem cell line. , 1999, Journal of hematotherapy & stem cell research.

[67]  R. Oreffo,et al.  Effects of TGFβ and BFGF on the differentiation of human bone marrow stromal fibroblasts , 1999, Cell biology international.

[68]  A. Canfield,et al.  Vascular Pericytes Express Osteogenic Potential In Vitro and In Vivo , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[69]  J. Glowacki,et al.  Three-dimensional composite of demineralized bone powder and collagen for in vitro analysis of chondroinduction of human dermal fibroblasts. , 1996, Biomaterials.

[70]  J. Zerwekh,et al.  Porous ceramics as bone graft substitutes in long bone defects: A biomechanical, histological, and radiographic analysis , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[71]  C. Basilico,et al.  Effects of fibroblast growth factor-4 (k-FGF) on long-term cultures of human bone marrow cells. , 1996, Blood.

[72]  A I Caplan,et al.  A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. , 1995, Experimental cell research.

[73]  S. Gronthos,et al.  The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. , 1995, Blood.

[74]  V. Jansson,et al.  Bone formation in coralline hydroxyapatite. Effects of pore size studied in rabbits. , 1994, Acta orthopaedica Scandinavica.

[75]  C. Misch,et al.  BONE‐GRAFTING MATERIALS IN IMPLANT DENTISTRY , 1993, Implant dentistry.

[76]  D. Sartoris,et al.  Coralline hydroxyapatite bone graft substitutes: radiographic evaluation. , 1992, The Journal of foot surgery.

[77]  D. Erickson.  Painkiller. There's still room for luck in industrial chemistry. , 1991, Scientific American.

[78]  H Oonishi,et al.  Orthopaedic applications of hydroxyapatite. , 1991, Biomaterials.

[79]  E. Luria,et al.  Fibroblast Colony Formation from Monolayer Cultures of Blood Cells , 1971, Transfusion.

[80]  A. Friedenstein,et al.  Osteogenesis in transplants of bone marrow cells. , 1966, Journal of embryology and experimental morphology.

[81]  W. Weimar,et al.  No evidence for circulating mesenchymal stem cells in patients with organ injury. , 2014, Stem cells and development.

[82]  A. Barrett,et al.  Bone marrow mesenchymal stromal cells to treat complications following allogeneic stem cell transplantation. , 2014, Tissue engineering. Part B, Reviews.

[83]  J. F. Osborn,et al.  Hydroxyapatite ceramic as a bone substitute , 2004, International Orthopaedics.

[84]  P. Breton,et al.  [Hydroxyapatite in orthognathic surgery. Animal experimentation and clinical applications]. , 1993, Revue de stomatologie et de chirurgie maxillo-faciale.

[85]  D. Erickson.  Binding bone. Will new bioceramic coatings improve orthopedic implants? , 1991, Scientific American.

[86]  Level,et al.  Stem Cells and Cloning: Advances and Applications Dovepress Adult Human Mesenchymal Stromal Cells and the Treatment of Graft versus Host Disease , 2022 .